Replies to post #17758 on Oncolix Inc. (fka ONCX)

[reaper247]

Thanks steady, I was surprised that there wasn’t more debate on this one today.

Redman and Taylor have controlling interest in Oncolix through a combination of 140,000,000 common and preferred shares. A few insiders contribute a little to that overall voting block.

The point is this. It doesn’t matter if the A/S is 950M or 8B. ONCX cant dilute much without diluting away their controlling interest.

I have tried to make this point over and over.

Most OTC stocks have some form of super preferreds that ensure the CEO maintains a controlling interest, no matter how much dilution there is to common shares.

As an example, a typical OTC stock could have10M super preferred shares with voting rights that convert 1:1000 into commons. That super preferred share voting block allows the company to dilute 9+B common shares and still maintain controlling interest and people never see it coming.

ONCX is structured differently.

They cant just dump 8B shares into the O/S and float while maintaining their controlling interest.

There is something else happening and I think we will get an update before the end of the month.

Not sure what that update will look like, but it doesn’t look like ONCX is just gonna cover notes on the backs of shareholders and then R/S.

GLTA, IMO and FWIW.